DK0636020T3 - Farmaceutisk bærersystem indeholdende definerede lipider - Google Patents

Farmaceutisk bærersystem indeholdende definerede lipider

Info

Publication number
DK0636020T3
DK0636020T3 DK93908232T DK93908232T DK0636020T3 DK 0636020 T3 DK0636020 T3 DK 0636020T3 DK 93908232 T DK93908232 T DK 93908232T DK 93908232 T DK93908232 T DK 93908232T DK 0636020 T3 DK0636020 T3 DK 0636020T3
Authority
DK
Denmark
Prior art keywords
pct
carrier system
system containing
pharmaceutical carrier
lipid
Prior art date
Application number
DK93908232T
Other languages
English (en)
Inventor
Hakan Nyqvist
Gert Ragnarsson
Per Tingvall
Original Assignee
Scotia Lipidteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Lipidteknik Ab filed Critical Scotia Lipidteknik Ab
Application granted granted Critical
Publication of DK0636020T3 publication Critical patent/DK0636020T3/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1274Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]
DK93908232T 1992-03-27 1993-03-26 Farmaceutisk bærersystem indeholdende definerede lipider DK0636020T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9200952A SE9200952D0 (sv) 1992-03-27 1992-03-27 Pharmaceutical carrier system containing defined lipids
PCT/SE1993/000257 WO1993019736A1 (en) 1992-03-27 1993-03-26 A pharmaceutical carrier system containing defined lipids

Publications (1)

Publication Number Publication Date
DK0636020T3 true DK0636020T3 (da) 1999-11-15

Family

ID=20385758

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93908232T DK0636020T3 (da) 1992-03-27 1993-03-26 Farmaceutisk bærersystem indeholdende definerede lipider

Country Status (10)

Country Link
US (1) US5635205A (da)
EP (1) EP0636020B1 (da)
JP (1) JPH07508708A (da)
AT (1) ATE179885T1 (da)
DE (1) DE69324914T2 (da)
DK (1) DK0636020T3 (da)
FI (1) FI114140B (da)
NO (1) NO308984B1 (da)
SE (1) SE9200952D0 (da)
WO (1) WO1993019736A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
ATE183092T1 (de) * 1995-10-28 1999-08-15 Braun Melsungen Ag Lokalanästhetika und/oder zentralanalgetika enthaltende pharmazeutische zusammensetzungen
JP2001524958A (ja) * 1997-04-17 2001-12-04 ジーエス ディベロップメント アクティエボラーグ 新規な液晶をベースとする生物接着性薬剤送出系
DE69841598D1 (de) * 1997-09-18 2010-05-20 Pacira Pharmaceuticals Inc Retardierte freisetzung liposmaler anesthetischer zusammensetzungen.
US20020039596A1 (en) 1997-11-14 2002-04-04 Hartoun Hartounian Production of multivesicular liposomes
ATE428371T1 (de) 1998-07-17 2009-05-15 Pacira Pharmaceuticals Inc Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
ATE272391T1 (de) 1998-12-23 2004-08-15 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
AU2002322024B2 (en) * 2001-05-31 2008-05-08 Pacira Pharmaceuticals, Inc. Encapsulation of nanosuspensions in liposomes and microspheres
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
WO2011121034A2 (en) 2010-04-01 2011-10-06 Pharmanest Ab Water-free pharmaceutical compositions suitable for local anaesthetics
WO2013168167A1 (en) 2012-05-10 2013-11-14 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
KR101768843B1 (ko) * 2013-02-28 2017-08-17 미라 파마 코포레이션 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158441B2 (en) * 1984-03-08 2001-04-04 Phares Pharmaceutical Research N.V. Liposome-forming composition
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system

Also Published As

Publication number Publication date
WO1993019736A1 (en) 1993-10-14
ATE179885T1 (de) 1999-05-15
FI944441A (fi) 1994-09-26
DE69324914D1 (de) 1999-06-17
NO943543D0 (no) 1994-09-23
NO308984B1 (no) 2000-11-27
JPH07508708A (ja) 1995-09-28
EP0636020A1 (en) 1995-02-01
DE69324914T2 (de) 1999-12-09
US5635205A (en) 1997-06-03
FI114140B (fi) 2004-08-31
NO943543L (no) 1994-09-23
EP0636020B1 (en) 1999-05-12
SE9200952D0 (sv) 1992-03-27
FI944441A0 (fi) 1994-09-26

Similar Documents

Publication Publication Date Title
DK0636020T3 (da) Farmaceutisk bærersystem indeholdende definerede lipider
ATE333867T1 (de) Emulgierte arzneistoffabgabesysteme
DK398587D0 (da) Antitumorvirksomt laegemiddel
ES2110543T3 (es) Derivados de poli(vinil-aminas) que tienen centros hidrofilos, procedimiento para su preparacion asi como la utilizacion de los compuestos como medicamentos, vehiculos de sustancias activas e ingredientes auxiliares para alimentos.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2123660T3 (es) Composiciones para administracion nasal que contienen metabolitos polares de analgesicos opioides.
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
ATE154235T1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
DK0615443T3 (da) Lægemiddel i akut virksom form indeholdende Flurbiprofen og anvendelse deraf
BR9306412A (pt) Formulaç o pesticida tixotrópica e método para proteç o de plantaç es
MC1930A1 (fr) Produit antiviral
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
DE69023241D1 (de) Ionophore enthaltende abgabevorrichtung.